Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Filings indexed 331 across all filing types
Latest filing 2026-03-16 Board/Management Inform…
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
General Meeting Request
Board/Management Information Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Physiomics plc regarding a 'General Meeting Request' submitted by a shareholder under section 303 of the Companies Act 2006. The request involves the proposed appointment of new directors and the removal of existing ones. Since this document is an announcement regarding a potential change in board composition and management structure, it falls under the 'Board/Management Information' category.
2026-03-16 English
Result of WRAP Retail Offer
Capital/Financing Update Classification · 1% confidence The document is an announcement regarding the completion of a 'WRAP Retail Offer' and a 'Fundraise' by Physiomics plc. It details the gross proceeds raised, the number of new ordinary shares issued, and the conditions of the offer. This falls under the category of capital raising and financing activities. While it mentions a General Meeting, the primary purpose of the document is to report on the successful completion of a capital raise (share issuance). Therefore, it is classified as a Capital/Financing Update.
2026-03-13 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their voting rights in a company cross a specific threshold. This fits the definition of a 'Major Shareholding Notification' (MRQ).
2026-03-11 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory disclosure form used in the UK to notify the market and the issuer when a shareholder's interest crosses a specific threshold (in this case, increasing from 8.01% to 13.68%). This fits the definition of a 'Major Shareholding Notification' (MRQ).
2026-03-11 English
WRAP Retail Offer for up to £49,999.98
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from Physiomics PLC regarding a 'WRAP Retail Offer' to raise capital through the issuance of new ordinary shares. It details the fundraising amount, the share price, the relationship to a concurrent 'Placing', and the requirement for shareholder approval at a General Meeting. As this document describes a specific capital-raising activity and the issuance of new shares, it falls under the 'Capital/Financing Update' category.
2026-03-10 English
Completion of Placing, Retail Offer & Notice of GM
Capital/Financing Update Classification · 1% confidence The document is an RNS announcement from Physiomics plc detailing a capital raise through a placing and a retail offer, as well as a notice of a general meeting to approve these actions. While it mentions a 'Notice of General Meeting', the primary purpose of the document is to announce the financing activity (placing and retail offer) and the associated capital structure changes. Therefore, it is best classified as a Capital/Financing Update.
2026-03-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.